Expert Interviews

Pearls for Primary Care: How to Talk About Agitation in Alzheimer Disease with Caregivers
December 04, 2024

A geriatric psychiatrist talks about the importance of asking caregivers about behavior in order to understand and treat agitation in Alzheimer dementia.

Counseling Patients on False Positives in cfDNA Blood-Based Colorectal Cancer Screening
December 02, 2024

William Grady, MD, highlights ongoing efforts to improve test sensitivity and developments of new blood-based tests for early detection of CRC.

Colorectal Cancer Screening: Considerations for Using Cell-Free DNA Blood Tests in Older Adults
November 28, 2024

William Grady, MD, coauthor of the ECLIPSE study, discusses the use of non-invasive cfDNA blood-based tests for CRC screening in older adults.

The Future of GLP-1RAs in Obesity Treatment: Expert Perspective
November 27, 2024

With the recent surge in demand and supply shortages, Michael Crotty, MD, discusses the future of GLP-1RA use in the treatment of obesity.

How Primary Care Physicians Can Approach the Use of GLP-1 Receptor Agonists for Weight Loss
November 27, 2024

Michael Crotty, MD, provides practical guidance for on integrating GLP-1 receptor agonists into a comprehensive obesity treatment plan.

GLP-1RAs for Weight Management: Weighing Benefits vs Side Effects
November 27, 2024

Obesity medicine specialist Michael Crotty, MD, discusses the benefits of GLP-1 receptor agonist use in weight management and its impact on obesity-related comorbidities.

Guidance for PCPs: Streamlining Menopause Care
November 25, 2024

Panelists discuss strategies for simplifying complex information for primary care physicians (PCPs), provide tips on how PCPs can effectively communicate evidence-based treatment options to patients, and outline actionable points and key takeaways to enhance patient care in managing menopause symptoms.

Nonestrogen Treatments for Menopause
November 25, 2024

Panelists discuss alternative therapies for women who are not candidates for or choose not to use hormonal therapy, review nonhormonal treatment options recommended by the North American Menopause Society, and explore the growing importance of Level I evidence and consensus opinions in creating a more holistic view of available therapies, both hormonal and nonhormonal.

VMS Treatment Guidelines
November 25, 2024

Panelists discuss key considerations for women taking hormonal therapy, emphasizing the importance of individualized treatment plans and shared decision-making to evaluate the risk-benefit profile of therapy.

Malignancy Risks of Neurokinin Receptor Antagonists
November 25, 2024

Panelists discuss clinical trial data suggesting a small but higher incidence of endometrial hyperplasia or malignancy with fezolinetant, while no cases of endometrial hyperplasia or malignancy were observed with elinzanetant in a long-term safety study.